Current issue
Archive
Videos
Articles in press
About the journal
Supplements
Editorial board
Reviewers
Abstracting and indexing
Subscription
Contact
Instructions for authors
Publication charge
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
4/2021
vol. 123 abstract:
Original paper
Three-year outcomes of treatment of wet age-related macular degeneration in the Polish therapeutic program
Małgorzata Figurska
1
KLINIKA OCZNA 2021, 123, 4: 194-202
Online publish date: 2021/12/17
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Introduction
Three-year evaluation of outcomes of wet age-related macular degeneration treatment with intravitreal injections of aflibercept and ranibizumab in routine clinical practice within the framework of the Polish National Health Fund therapeutic program. Material and methods A total of 135 patients (135 eyes), with a median age of 82.0 [74.0, 86.5] years were enrolled in a non-randomized, retrospective, observational, single-center study. A total of 78 (57.8%) eyes were treatment-naive. Treatment was provided in accordance with the guidelines set out in the therapeutic program, based on a fixed or pro re nata regimen. Results After the first year of treatment, there was a mean gain of 4.86 [12.50], after the second year 4.72 [12.67] (p> 0.05), and after the third year a significantly lower gain of 3.26 [12.21] ETDRS letters. A significant reduction in central retinal thickness was observed. In the first year, 8.00 [6.00, 8.00] injections were performed. In the following years, the number was significantly smaller (5.00 [4.00, 6.00]). In the treatment-naive subgroup, the best corrected visual acuity improved significantly during the first and second years of treatment, and was significantly higher compared to the pretreated subgroup. Conclusions Regular treatment of wet age-related macular degeneration in line with the guidelines set out in the therapeutic program leads to functional stabilization and significant morphological improvement over a long-term follow-up (3 years), with significantly fewer injections administered after the first year of treatment. During the initial two years of the therapeutic program, treatment-naive eyes exhibited significantly higher functional parameters compared to pretreated eyes. keywords:
wet age-related macular degeneration, intravitreal injections, aflibercept, ranibizumab, electronic database |
|